Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02676986
Title Short-term Preoperative Treatment With Enzalutamide, Alone or in Combination With Exemestane in Primary Breast Cancer (ARB)
Acronym ARB
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Queen Mary University of London
Age Groups: adult | senior
Covered Countries USA | GBR | ESP | DEU

No variant requirements are available.